Skip to content

Metabolomics in high performance sports: effects of endurance- and strength-specific stimuli on the metabolic profile of elite athletes

Metabolomics in high performance sports: effects of endurance- and strength-specific stimuli on the metabolic profile of elite athletes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015511
Enrollment
32
Registered
2019-01-10
Start date
2019-01-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy athletes and non-athletes

Interventions

Group 1: Endurance-trained athletes: at each time-point of measurement (I-III), anthropometric data (height, weight, skin fold thickness measurement) are determined, as well as a treadmill ergometry (

Sponsors

Universitätsklinikum Heidelberg, Innere Medizin VII: Sportmedizin
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Endurance-trained athletes: national and regional high performance athletes, VO2max > 60ml/kg/min, several years of running experience and participation in national and international competitions. Strength-trained athletes: national and regional high performance athletes, several years of strength training experience or participation in national or international competitions. Sedentary controls: no regular training activities (< 2x/wk physically active, e.g. driving short distances with a bike, garden works, recreational swimming).

Exclusion criteria

Exclusion criteria: - minority - incapacity to consent - diseases (abnormalities) of the musculoskeletal system such as osteoarthritis, spondylarthrosis, joint or spinal deformity - cardiovascular diseases (e.g. hypertension, coronary heart disease, haemodynamically relevant valve viability, severe cardiac arrhythmia) - any acute or chronic disease (e.g. infectious diseases) - disturbance of coagulation activity - anamnestic information on muscle disease - regular medication, in particular non-steroidal anti-inflammatory drugs - intake of food supplements, in particular creatine, carbohydrate, ß-alanine

Design outcomes

Primary

MeasureTime frame
Changes of the metabolic profile, which will be explained by the concentration and composition or change of the metabolites. Effects between the groups (i) endurance- and strength-trained athletes, as well as between the two groups of athletes and the sedentarycontrols will be investigates as well as (ii) acute exercise-induced effects and longitudinal changes over the training year (= between timepoint 1, timepoint 2 and timepoint 3). Measurements: Detection of metabolites using GC/MS in venous and capillary blood samples at rest and after a specific exercise test (treadmill test and threshold test or strength test) at three time points in the course of a training year.

Secondary

MeasureTime frame
no secondary outcome

Countries

Germany

Contacts

Public ContactMario Parstorfer

Universitätsklinikum Heidelberg, Innere Medizin VII: Sportmedizin

Mario.Parstorfer@med.uni-heidelberg.de06221568105

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026